Skip to main content

Table 3 Multivariable hazard ratios of mortality for IBD patients registered in the Catastrophic Illness Registry, Taiwan, 2001–2015

From: Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study

 

UC

CD

cHR

95% CI

aHRa

95% CI

cHR

95% CI

aHRb

95% CI

Gender

 Female

1.00

(Ref.)

  

1.00

(Ref.)

1.00

(Ref.)

 Male

1.29

(0.97–1.71)

  

0.65

(0.43–0.97)

1.04

(0.65–1.66)

IBD registered age

  ≤ 39

1.00

(Ref.)

1.00

(Ref.)

1.00

(Ref.)

1.00

(Ref.)

 40–59

2.23

(1.39–3.59)

2.21

(1.37–3.59)

2.91

(1.63–5.22)

3.11

(1.69–5.72)

  ≥ 60

14.16

(9.16–21.88)

8.93

(5.50–14.52)

13.95

(8.28–23.50)

11.93

(6.25–22.79)

Operation

 Colostomy

3.67

(2.51–5.37)

1.28

(0.83–1.95)

3.66

(2.26–5.95)

2.27

(1.33–3.87)

 Exploratory laparotomy

5.04

(1.87–13.59)

2.41

(0.84–6.88)

3.57

(1.79–7.10)

2.27

(1.04–4.98)

 Ileostomy

2.69

(1.64–4.42)

1.34

(0.79–2.27)

3.13

(1.51–6.45)

2.26

(1.04–4.90)

Comorbidity

 Hypertension

2.35

(1.80–3.08)

0.69

(0.50–0.95)

2.96

(1.96–4.47)

0.68

(0.39–1.19)

 Diabetes

2.17

(1.57–2.99)

0.76

(0.53–1.09)

2.33

(1.41–3.85)

0.67

(0.35–1.28)

 Hyperlipidemia

0.84

(0.60–1.18)

  

1.66

(1.01–2.71)

0.76

(0.41–1.40)

 COPD

2.52

(1.79–3.55)

0.82

(0.56–1.18)

1.70

(0.88–3.28)

  

EIM

 Cholangitis

3.81

(1.79–8.09)

2.14

(0.95–4.81)

2.35

(0.86–6.40)

  

 Deep vein thrombosis

1.99

(0.82–4.83)

  

3.14

(1.28–7.74)

1.14

(0.44–2.98)

 Pulmonary embolism

8.76

(2.17–35.43)

4.21

(1.01–17.57)

4.75

(0.66–34.24)

  

Complication

        

 Fistula

0.91

(0.60–1.37)

  

0.38

(0.21–0.68)

0.60

(0.32–1.10)

Cancer

 Colorectal cancer

6.61

(3.50–12.49)

1.84

(0.94–3.61)

3.46

(1.09–10.92)

1.04

(0.27–3.96)

 Liver cancer

8.59

(4.40–16.75)

2.16

(1.05–4.42)

14.96

(3.67–60.95)

1.80

(0.36–9.07)

 Lymphoma

9.25

(3.81–22.48)

3.65

(1.45–9.19)

7.38

(1.81–30.03)

12.26

(2.85–52.63)

Hospitalization

 Pneumonia

11.23

(8.57–14.70)

2.88

(2.08–3.99)

5.27

(3.48–7.98)

1.79

(1.13–2.85)

 Urinary tract infection

5.18

(3.89–6.91)

0.87

(0.62–1.22)

2.52

(1.60–3.97)

0.78

(0.44–1.38)

 Spesis

13.09

(9.98–17.16)

5.40

(3.86–7.56)

6.53

(4.34–9.81)

5.36

(3.41–8.41)

  1. cHR crude hazard ratio, aHR adjusted hazard ratio, CI confidence interval
  2. aAdjusted risk factor: IBD registered age, Colostomy, Exploratory laparotomy, Ileostomy, Hypertension, Diabetes, COPD, Cholangitis, Pulmonary embolism, Colorectal cancer, Liver cancer, lymphoma, Pneumonia, Urinary tract infection, Sepsis
  3. bAdjusted risk factor: Gender, IBD registered age, Colostomy, Exploratory laparotomy, Ileostomy, Hypertension, Diabetes, Hyperlipidemia, Deep vein thrombosis, Fistula, Colorectal cancer, Liver cancer, lymphoma, Pneumonia, Urinary tract infection, Sepsis